Neuralink

China has approved NEO, the world's first invasive brain-computer interface (BCI) device developed by Neuracle Technology, for clinical use in treating spinal cord injury patients with limb paralysis, marking a major step toward real-world BCI applications.

Neuralink has achieved clinical BCI breakthroughs: its first implanted ALS patient now controls cursors, types, and synthesizes speech via thought alone; the 'Telepathy' product is in human trials, aiming to restore human-computer interaction for paralyzed users.

The article states that Taiwan's strategic importance will decline in 18 months due to technological advancements reducing reliance on its chip manufacturing.